Potential therapeutic and pharmacological strategies for SARS-CoV2

被引:0
|
作者
Doaa A. Ghareeb
Samar R. Saleh
Mohammed S. Nofal
Mohamed M. Y. Kaddah
Salma. F. Hassan
Inas K. Seif
Sally A. El-Zahaby
Shaimaa M. Khedr
Marwa Y. Kenawy
Aliaa A. Masoud
Salma A. Soudi
Ahmed A. Sobhy
Jaillan G. Sery
Miral G. Abd El-Wahab
Alshimaa A. Abd Elmoneam
Abdulaziz Mohsen Al-mahallawi
Maha A. El-Demellawy
机构
[1] Alexandria University,Biological Screening and Preclinical Trial Laboratory, Department of Biochemistry, Faculty of Science
[2] City of Scientific Research and Technological Applications (SRTA-City),Pharmaceutical and Fermentation Industries Development Centre (PFIDC)
[3] Pharos University in Alexandria,Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy
[4] City of Scientific Research and Technological Applications (SRTA-City),Fabrication Technology Department, Advanced Technology and New Materials Research Institute (ATNMRI)
[5] Alexandria University,Clinical Pharmacy Program, Faculty of Pharmacy
[6] Cairo University,Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy
[7] October University for Modern Sciences and Arts (MSA),Department of Pharmaceutics, Faculty of Pharmacy
[8] GEBRI,Medical Biotechnology Department
[9] SRTA-City,undefined
来源
Journal of Pharmaceutical Investigation | 2021年 / 51卷
关键词
COVID-19; Hydroxychloroquine; Indomethacin; Tocilizumab; Teicoplanin; Camostat;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:281 / 296
页数:15
相关论文
共 50 条
  • [1] Potential therapeutic and pharmacological strategies for SARS-CoV2
    Ghareeb, Doaa A.
    Saleh, Samar R.
    Nofal, Mohammed S.
    Kaddah, Mohamed M. Y.
    Hassan, Salma. F.
    Seif, Inas K.
    El-Zahaby, Sally A.
    Khedr, Shaimaa M.
    Kenawy, Marwa Y.
    Masoud, Aliaa A.
    Soudi, Salma A.
    Sobhy, Ahmed A.
    Sery, Jaillan G.
    El-Wahab, Miral G. Abd
    Elmoneam, Alshimaa A. Abd
    Al-mahallawi, Abdulaziz Mohsen
    El-Demellawy, Maha A.
    JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2021, 51 (03) : 281 - 296
  • [2] From SARS-CoV to SARS-CoV2: a potentia guide to better understanding of pathophysiology of the disease and potential therapeutic modality
    Pashaki, P. Abbasi
    Roudkenar, M. Habibi
    Rahim, F.
    Ebrahimi, A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (14) : 7816 - 7825
  • [3] Food spices as potential therapeutic agents in targeting inflammatory cytokine storm: A review on underlying mechanisms and therapeutic targeting strategies for SARS-CoV2
    Rathod, Priyanka
    Yadav, Raman P.
    INDIAN JOURNAL OF NATURAL PRODUCTS AND RESOURCES, 2023, 14 (02): : 185 - 201
  • [4] Neuromodulatory effects of SARS-CoV2 infection: Possible therapeutic targets
    Kumar, Sonali
    Shanker, Ozasvi R.
    Kumari, Neeraj
    Tripathi, Manjari
    Chandra, P. Sarat
    Dixit, Aparna Banerjee
    Banerjee, Jyotirmoy
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2021, 25 (06) : 509 - 519
  • [5] In silico Study of Pharmacological Treatments against SARS-CoV2 Main Protease
    Kadil, Youness
    Mouhcine, Mohamed
    Filali, Houda
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2020, 14 : 1065 - 1071
  • [6] Olfactory dysfunction and SARS-CoV2
    Bonfils, Pierre
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2023, 207 (08): : 1075 - 1083
  • [7] 17β-Estradiol, a potential ally to alleviate SARS-CoV2 infection
    Breithaupt-Faloppa, Ana Cristina
    Correia, Cristiano de Jesus
    Prado, Carla Maximo
    Stilhano, Roberta Sessa
    Ureshino, Rodrigo Portes
    Pinho Moreira, Luiz Felipe
    CLINICS, 2020, 75 : 1 - 8
  • [8] Inhaled interferons beta and SARS-COV2 infection: a preliminary therapeutic perspective
    Cojocaru, Elena
    Cojocaru, Cristian
    Antoniu, Sabina Antonela
    Stafie, Celina Silvia
    Rajnoveanu, Armand
    Rajnoveanu, Ruxandra-Mioara
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2022, 16 (03) : 257 - 261
  • [9] Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19
    Lega, Sara
    Naviglio, Samuele
    Volpi, Stefano
    Tommasini, Alberto
    VACCINES, 2020, 8 (02)
  • [10] Microfluidic strategies for biomimetic lung chip establishment and SARS-CoV2 study
    Wang, Hui
    Wen, Tingqing
    Zhu, Wan
    Li, Keke
    Gong, Xiaojie
    Li, Zhongyu
    MATERIALS TODAY BIO, 2024, 24